Amgen News

Amgen | 144: Notice of proposed sale of securities pursuant to Rule 144

May 4 07:22

Amgen | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 5, 2023 08:40

Amgen | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 9, 2023 03:11

Amgen | 144: Notice of proposed sale of securities pursuant to Rule 144

Aug 11, 2023 03:18

Amgen | 424B2: Prospectus

Feb 17, 2023 08:41

Amgen | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Feb 16, 2023 08:04

Amgen | 424B3: Prospectus

Feb 14, 2023 22:20

Amgen | 424B2: Prospectus

Aug 17, 2022 05:20

Amgen | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Aug 16, 2022 06:06

Amgen | 424B3: Prospectus

Aug 15, 2022 20:48

Amgen | 424B2: Prospectus

Feb 19, 2022 05:09

Amgen | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Feb 18, 2022 06:23

Amgen | 424B3: Prospectus

Feb 17, 2022 21:53

Amgen | 424B2: Prospectus

Aug 7, 2021 05:03

Amgen | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Aug 6, 2021 07:28

Amgen | 424B3: Prospectus

Aug 5, 2021 20:31

Amgen | EFFECT: Others

Apr 16, 2021 12:15

Amgen | 424B3: Prospectus

Apr 16, 2021 04:13

Amgen | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Apr 7, 2021 04:02

Amgen | S-4: Registration of securities issued in business combination transactions

Feb 10, 2021 05:45